Paper22067048
Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis.
Machalińska A and 3 others. Acta Ophthalmol, 2012. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis. Papers, record 22067048. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22067048
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| Complement Activation | Major topic |
| Endothelium, Vascular | Major topic |
| Macular Degeneration | Major topic |
| Animals | |
| Complement Factor H | |
| Complement System Proteins | |
| Humans | |
| Polymorphism, Single Nucleotide |
Source PubMed
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41752079 | Structure and Function of Ocular Proteoglycans: Essential Proteins for Vision. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752079 | PubMed |
| 41457155 | Luteolin alleviates angiogenesis in HUVECs by inhibiting VEGFA expression: integrating network pharmacology and experimental validation. | Sci Rep | 2025 | https://conductscience.org/library/papers/41457155 | PubMed |
| 40261662 | Associations of Cardiovascular Health and New-Onset Age-Related Macular Diseases From UK Biobank. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40261662 | PubMed |
| 38892113 | Metabolic Regulation of Endothelial Cells: A New Era for Treating Wet Age-Related Macular Degeneration. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892113 | PubMed |
| 38731137 | Drusen in AMD from the Perspective of Cholesterol Metabolism and Hypoxic Response. | J Clin Med | 2024 | https://conductscience.org/library/papers/38731137 | PubMed |
| 38672719 | Retinal Structural and Vascular Changes in Patients with Coronary Artery Disease: A Systematic Review and Meta-Analysis. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38672719 | PubMed |
| 37841646 | The effect of off-pump coronary bypass graft surgery on subfoveal choroidal thickness, ganglion cell complex, and retinal nerve fiber layer thickness. | Ther Adv Ophthalmol | 2023 | https://conductscience.org/library/papers/37841646 | PubMed |
| 37587376 | Coronary artery disease, its associations with ocular, genetic and blood lipid parameters. | Eye (Lond) | 2024 | https://conductscience.org/library/papers/37587376 | PubMed |
| 37511686 | Classification Maps: A New Mathematical Tool Supporting the Diagnosis of Age-Related Macular Degeneration. | J Pers Med | 2023 | https://conductscience.org/library/papers/37511686 | PubMed |
| 35329812 | AMD Genomics: Non-Coding RNAs as Biomarkers and Therapeutic Targets. | J Clin Med | 2022 | https://conductscience.org/library/papers/35329812 | PubMed |
| 35252605 | A histological study of atherosclerotic characteristics in age-related macular degeneration. | Heliyon | 2022 | https://conductscience.org/library/papers/35252605 | PubMed |
| 35110596 | Association of neovascular age-related macular degeneration with migraine. | Sci Rep | 2022 | https://conductscience.org/library/papers/35110596 | PubMed |
| 35048199 | Choroidal vascularity index in eyes with central macular atrophy secondary to age-related macular degeneration and Stargardt disease. | Graefes Arch Clin Exp Ophthalmol | 2022 | https://conductscience.org/library/papers/35048199 | PubMed |
| 34640613 | Efficacy of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-Related Macular Degeneration and Systemic Cardiovascular Risk Factors. | J Clin Med | 2021 | https://conductscience.org/library/papers/34640613 | PubMed |
| 33997607 | Is there a relationship between hematological inflammatory parameters and age-related macular degeneration? | Ther Adv Ophthalmol | 2021 | https://conductscience.org/library/papers/33997607 | PubMed |
| 33742280 | Geographic atrophy severity and mortality in age-related macular degeneration. | Graefes Arch Clin Exp Ophthalmol | 2021 | https://conductscience.org/library/papers/33742280 | PubMed |
| 32985463 | MicroRNAs as diagnostic and prognostic biomarkers of age-related macular degeneration: advances and limitations. | Neural Regen Res | 2021 | https://conductscience.org/library/papers/32985463 | PubMed |
| 31975437 | C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke. | Br J Pharmacol | 2020 | https://conductscience.org/library/papers/31975437 | PubMed |
| 31849644 | Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31849644 | PubMed |
| 31731799 | Associations of microRNAs, Angiogenesis-Regulating Factors and CFH Y402H Polymorphism-An Attempt to Search for Systemic Biomarkers in Age-Related Macular Degeneration. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31731799 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFH | 3075 | PubTator's text mining | https://conductscience.org/library/genes/3075 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22067048
GET https://conductscience.org/api/papers/v1/22067048/cited_by?page=2